137 related articles for article (PubMed ID: 11237260)
1. Inhibition of human topoisomerase II by the antitumor metallocenes.
Mokdsi G; Harding MM
J Inorg Biochem; 2001 Jan; 83(2-3):205-9. PubMed ID: 11237260
[TBL] [Abstract][Full Text] [Related]
2. Organometallic anticancer agents: the effect of the central metal and halide ligands on the interaction of metallocene dihalides Cp2MX2 with nucleic acid constituents.
Murray JH; Harding MM
J Med Chem; 1994 Jun; 37(13):1936-41. PubMed ID: 8027975
[TBL] [Abstract][Full Text] [Related]
3. Disulfiram is a potent in vitro inhibitor of DNA topoisomerases.
Yakisich JS; Sidén A; Eneroth P; Cruz M
Biochem Biophys Res Commun; 2001 Nov; 289(2):586-90. PubMed ID: 11716515
[TBL] [Abstract][Full Text] [Related]
4. Organometallic anticancer agents. 2. Aqueous chemistry and interaction of niobocene dichloride with nucleic acid constituents and amino acids.
Harding MM; Prodigalidad M; Lynch MJ
J Med Chem; 1996 Dec; 39(25):5012-6. PubMed ID: 8960562
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerase II-mediated cleavage of plasmid DNA.
Burden DA; Froelich-Ammon SJ; Osheroff N
Methods Mol Biol; 2001; 95():283-9. PubMed ID: 11089240
[No Abstract] [Full Text] [Related]
6. Bimolane: in vitro inhibitor of human topoisomerase II.
Frantz CE; Smith H; Eades DM; Grosovsky AJ; Eastmond DA
Cancer Lett; 1997 Dec; 120(2):135-40. PubMed ID: 9461029
[TBL] [Abstract][Full Text] [Related]
7. Glucosylated isoflavones as DNA topoisomerase II poisons.
Martín-Cordero C; López-Lazaro M; Piñero J; Ortiz T; Cortés F; Ayuso MJ
J Enzyme Inhib; 2000; 15(5):455-60. PubMed ID: 11030085
[TBL] [Abstract][Full Text] [Related]
8. A (1)H NMR study of the interaction of antitumor metallocenes with glutathione.
Mokdsi G; Harding MM
J Inorg Biochem; 2001 Sep; 86(2-3):611-6. PubMed ID: 11566334
[TBL] [Abstract][Full Text] [Related]
9. Antitumour metallocenes: structure-activity studies and interactions with biomolecules.
Harding MM; Mokdsi G
Curr Med Chem; 2000 Dec; 7(12):1289-303. PubMed ID: 11032972
[TBL] [Abstract][Full Text] [Related]
10. Intracellular molecular interactions of antitumor drug amsacrine (m-AMSA) as revealed by surface-enhanced Raman spectroscopy.
Chourpa I; Morjani H; Riou JF; Manfait M
FEBS Lett; 1996 Nov; 397(1):61-4. PubMed ID: 8941714
[TBL] [Abstract][Full Text] [Related]
11. A 31P NMR study of the interaction of the antitumor active metallocene Cp2MoCl2 with calf thymus DNA.
Harding MM; Harden GJ; Field LD
FEBS Lett; 1993 May; 322(3):291-4. PubMed ID: 8486161
[TBL] [Abstract][Full Text] [Related]
12. DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition.
Fortune JM; Velea L; Graves DE; Utsugi T; Yamada Y; Osheroff N
Biochemistry; 1999 Nov; 38(47):15580-6. PubMed ID: 10569942
[TBL] [Abstract][Full Text] [Related]
13. Resistance to topoisomerase II poisons: is the answer in the promoter?
Kaufmann SH
Leuk Res; 1997; 21(11-12):1033-6. PubMed ID: 9444936
[No Abstract] [Full Text] [Related]
14. Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Thapa P; Karki R; Choi H; Choi JH; Yun M; Jeong BS; Jung MJ; Nam JM; Na Y; Cho WJ; Kwon Y; Lee ES
Bioorg Med Chem; 2010 Mar; 18(6):2245-2254. PubMed ID: 20188578
[TBL] [Abstract][Full Text] [Related]
15. Enhanced antitumour activity of cyclopendadienyl-substituted metallocene dihalides in human breast and colon cancer cells.
Stachtea X; Karamanos N; Klouras N
Anticancer Res; 2009 Aug; 29(8):3227-31. PubMed ID: 19661339
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory properties of antitumor prostaglandins against topoisomerases.
Suzuki K; Uyeda M
Biosci Biotechnol Biochem; 2002 Aug; 66(8):1706-12. PubMed ID: 12353631
[TBL] [Abstract][Full Text] [Related]
17. Sequence dependence of Drosophila topoisomerase II in plasmid relaxation and DNA binding.
Sander M; Hsieh T; Udvardy A; Schedl P
J Mol Biol; 1987 Mar; 194(2):219-29. PubMed ID: 3039151
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase II poisoning by indazole and imidazole complexes of ruthenium.
Vashisht Gopal YN; Kondapi AK
J Biosci; 2001 Jun; 26(2):271-6. PubMed ID: 11426063
[TBL] [Abstract][Full Text] [Related]
19. A high-throughput-compatible, fluorescence anisotropy-based assay for ATP-dependent supercoiled DNA relaxation by human topoisomerase IIα.
Shapiro AB
Biochem Pharmacol; 2013 May; 85(9):1269-77. PubMed ID: 23415903
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II.
Drake FH; Hofmann GA; Bartus HF; Mattern MR; Crooke ST; Mirabelli CK
Biochemistry; 1989 Oct; 28(20):8154-60. PubMed ID: 2557897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
